8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT

(DATE OF EARLIEST EVENT REPORTED)

December 4, 2006

ASTRO-MED, INC

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

COMMISSION FILE NUMBER0-13200

RHODE ISLAND	05-0318215
(STATE OR OTHER JURISDICTION OFINCORPORATION OR ORGANIZATION)	(IRS EMPLOYER IDENTIFICATIONNUMBER)

600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)

(401-828-4000)

(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE)

ITEM 7.01. Regulation FD Disclosure

On December 4, 2006, Astro-Med, Inc. (the “Company”) issued a press release confirming its previously issued earnings guidance for fiscal year 2007. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(c) Exhibit

Exhibit no. Exhibit

99.1 Press Release dated December 4, 2006

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.

DATE: December 4, 2006 ASTRO-MED, INC.

/s/ Joseph P. O’Connell

By: __________________________

Joseph P. O’Connell

Vice President, Treasurer and Chief Financial Officer

INDEX TO EXHIBITS

Exhibit No. Exhibit

99.1 Press Release dated December 4, 2006

EX-99

Exhibit 99.1

PRESS RELEASE

600 East Greenwich Avenue

West Warwick, Rhode Island 02893

Astro-Med Updates on Investor Relations Campaign

Contact: Albert W. Ondis, CEO

Joseph P. O’Connell, CFO December 4, 2006

Astro-Med, Inc.

(401) 828-4000

West Warwick, RI – December 4, 2006 – During the past year, Astro-Med, Inc. (NASDAQ:ALOT), along with its independent investor relations firm, SM Berger & Company, has increased efforts to communicate the Company’s investment merits to the investment community. Recently, the Company met with institutional investors in New York City and Boston. In 2007, the Company is scheduled to present at the Needham & Company Growth Conference in New York City, and at the AeA Micro Cap Financial Conference in Monterey, CA, in addition to private meetings with institutional investors in other financial centers. The Company’s most recent investment presentation is available on its web site, www.astro-medinc.com.

Albert W. Ondis, Chairman and Chief Executive Officer of Astro-Med, stated, “Astro-Med’s business outlook has never been better. We are committed to communicating the strong financial performance of the Company as well as its growth drivers, which are our innovative new products. These growth drivers include the Vivo! Digital Color Label Printing System, the Toughwriter Ruggedized Airborne Page Printing System, and the Aura PSG Wireless Sleep Study System.

“We remain optimistic that the Company will record significant financial growth in Fiscal 2007 with revenues over $65,000,000, compared to $59,301,000 last fiscal year. In addition, we estimate net income per diluted share to range between $0.36 and $0.42, which does not include income from the sale of real estate in the Fiscal 2007 third quarter.”

Mr. Ondis concluded, “Through November 30, 2006, Astro-Med’s stock has appreciated over 20 percent in the current fiscal year and we have increased the number of shares outstanding by splitting the stock five-for-four while maintaining our $0.05 quarterly cash dividend. We look forward to communicating our future successes with investors and plan to release our Fiscal 2007 full year and fourth quarter financial results in March 2007.”

2

Astro-Med, Inc. is a leading manufacturer of specialty instrument systems and supplies, marketed worldwide under the brand names Astro-Med, QuickLabel Systems and Grass Technologies. Astro-Med, Inc. products are employed around the world for industrial and scientific test and measurement applications, for product identification applications in consumer and industrial markets, and for clinical and research purposes in the field of life sciences.

Safe Harbor Statement

This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med’s FY2006 annual report and its annual and quarterly filings with the Securities and Exchange Commission.

# # #